LEADER 04369nam 22006374a 450 001 9910145737103321 005 20230721031326.0 010 $a1-281-32011-0 010 $a9786611320119 010 $a0-470-98481-3 010 $a0-470-98847-9 010 $a0-470-99409-6 035 $a(CKB)1000000000413718 035 $a(EBL)351110 035 $a(OCoLC)476170608 035 $a(SSID)ssj0000147171 035 $a(PQKBManifestationID)11146663 035 $a(PQKBTitleCode)TC0000147171 035 $a(PQKBWorkID)10010793 035 $a(PQKB)10519793 035 $a(MiAaPQ)EBC351110 035 $a(Au-PeEL)EBL351110 035 $a(CaPaEBR)ebr10236693 035 $a(CaONFJC)MIL132011 035 $a(EXLCZ)991000000000413718 100 $a20060621d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEndothelial dysfunctions and vascular disease$b[electronic resource] /$fedited by Raffaele De Caterina, Peter Libby ; foreword by Michael A. Gimbrone Jr 210 $aMalden, MA $cBlackwell Futura$d2007 215 $a1 online resource (432 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-2208-0 320 $aIncludes bibliographical references and index. 327 $aEndothelial Dysfunctions and Vascular Disease; Contents; Contributors; Preface; Foreword; Acknowledgments; Dedication; Part I: The basis of endothelial involvement in vascular diseases; 1 Endothelial functions and dysfunctions; 2 Endothelial activation and the initiation of atherosclerosis; 3 Mechanisms of plaque progression and complications; 4 Angiogenesis in cardiovascular disease; Part II: The endothelium and cardiovascular risk factors; 5 VLDL and atherosclerosis; 6 High-density lipoprotein and atheroprotection 327 $a7 Advanced glycation endproducts and the accelerated atherosclerosis in diabetes8 Homocysteine and endothelial dysfunction; 9 Lipoprotein(a) and the artery wall; 10 Oxidative stress and vascular disease; 11 Infections and vascular disease; Part III: Diagnostic tools and markers of endothelial functions; 12 Endothelial vasodilatory dysfunction: basic concepts and practical implementation; 13 Endothelial vasodilatory dysfunction and risk factors in adults; 14 Endothelial vasodilatory dysfunction in early life; 15 Endothelial vasodilatory dysfunction in hypertension 327 $a16 Vascular function and diabetes mellitus17 Dyslipidemia and endothelial dysfunction: pathophysiology and therapy; 18 Soluble adhesion molecules as in vivo biohumoral markers of vascular cell activation; Part IV: Endothelium-directed prevention and therapy; 19 Hormone replacement therapy and cardiovascular disease; 20 Anti-atherogenic effects of omega-3 fatty acids; 21 Treatment of endothelial dysfunction and atherosclerosis by cholesterol lowering; 22 Antioxidants and endothelial protection 327 $a23 Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers to reverse endothelial dysfunction24 PPARs in atherosclerosis; 25 Stem cells in atherosclerosis and atherosclerosisrelated vascular disorders; 26 Endothelium-targeted gene and cell-based therapy for cardiovascular disease; Index 330 $aBridging the gap between the laboratory and the bedside, this timely volume illuminates the connection between endothelial dysfunction and vascular disease. This comprehensive survey of atherosclerotic disease begins with biology - incorporating the latest breakthroughs in the field - then elucidates risk factors and diagnostic tools and markers. A major section on endothelium-directed prevention and therapy shows you how to apply cutting-edge research to clinical care. Under the careful editorial guidance of Drs. De Caterina and Libby, the highly-regarded contributors address:- endothel 606 $aBlood-vessels$xPathophysiology 606 $aVascular endothelium 615 0$aBlood-vessels$xPathophysiology. 615 0$aVascular endothelium. 676 $a616.1/3 701 $aDe Caterina$b R.$f1954-$0602130 701 $aLibby$b Peter$0750680 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910145737103321 996 $aEndothelial dysfunctions and vascular disease$92189336 997 $aUNINA